Abstract
Obstructive Sleep Apnoea (OSA) is a common sleep disorder associated with significant health, quality of life and psychosocial problems. The aims of this review are to investigate the contribution of psychological constructs and theory to the assessment and treatment of OSA. Adherence to CPAP treatment remains a primary concern for improving treatment outcomes for OSA. Modifiable, psychological constructs of self-efficacy, coping, social support, treatment satisfaction and self-reported daytime sleepiness improve the prediction of CPAP adherence. These predictors are particularly robust in the context of a theoretical Previous research investigating modifiable psychological constructs of CPAP adherence will be critically reviewed. The primary goal of this review is to present a new, integrated, theoretically sound psychological model of CPAP adherence that predicts patient acceptance and adherence to treatment. It will be argued that this model will provide a basis for the development of psychological interventions designed to improve overall CPAP adherence rates and treatment outcomes.
Clinical Presentation and Health Consequences of Obstructive Sleep Apnoea
Obstructive Sleep Apnoea (OSA) is associated with obstructions of the upper airway during sleep, which are caused by collapse of the dilator muscles and soft tissues of the pharyngeal wall. OSA may be diagnosed based on the presence of 5 or more of these respiratory events (Apnoea-Hypopnoea Index > 5) with concurrent evidence of OSA symptoms (daytime sleepiness, snoring and choking arousals from sleep). Alternatively, OSA is also diagnosed when patients display an AHI of greater than 15 events per hour 2002). Sleep apnoea is consistently more prevalent in males, with a male to female ratio of up to 8:1 (Perlis & Lichstein, 2003) .
Treatment of OSA
The current "Gold Standard" treatment for OSA is CPAP therapy. Pressurised air is administered through a nasal (nCPAP) or full face mask. This pressurised air functions as a pneumatic splint for the upper airway, preventing it from collapse. The pressure is titrated to a level that reduces the individual patient's AHI to less than 5 events per hour (Malhotra, Ayas, & Epstein, 2000; Stepnowsky & Moore, 2003) .
CPAP use reduces the risk of several adverse outcomes of OSA. There is a general reduction in the number of physician claims and in the length of hospital stays for patients on CPAP (Malhotra et al., 2000) . CPAP users are also at reduced risk for motor vehicle accidents compared to non-CPAP users (Engleman, Asgari-Jirhandeh, McLeod, Ramsay, Deary, & Douglas, 1996; Young et al., 2002) . Recent evidence suggests that CPAP may also be effective in reducing negative psychosocial and improving mental health outcomes of these patients (Fidan, Ünlü, Sezer, Geçici, & Kara, 2007) . The reduced daytime sleepiness noted during CPAP treatment is also associated with improvements in general quality of life for both the patient (Weaver, Maislin, Dinges, Bloxham, George, Greenberg, et al., 2007) and their partner (Kiely & McNicholas, 1997; Kingshott et al., 2000; McMahon, Foresman, & Chisholm, 2003) . Despite the numerous positive outcomes experienced by patients who use CPAP, the effectiveness of this treatment is limited by suboptimal adherence rates.
Adherence to CPAP
CPAP treatment of OSA can be awkward, and requires considerable alteration to a patient's lifestyle (Malhotra et al., 2000) . It has been estimated that 15 -30% of patients do not accept CPAP treatment from the outset, that is, before or during their titration study (Collard, Pieters, Aubert, Delguste, & Rodenstein, 1997; Fletcher & Luckett, 1991) . This early pattern of CPAP use is critical for determining continued patterns of use (Weaver, Grunstein, 2008) . Of those who do initially accept the treatment and take it home, 25 -50% of patients fail to adhere optimally to the treatment (Zozula & Rosen, 2001 ). In the long term, up to 25% of patients stop using the treatment by the third year (Engleman & Wild, 2003) .
Studies addressing adherence to CPAP up to five years follow-up, indicate that patients still using CPAP in the long term can be expected to use their CPAP machine, on average, between 4 and 5 hours per night at the prescribed pressure (Aloia, Arnedt, Stepnowsky, Hecht, & Borrelli, 2005; Bennet, Langford, Stradling, & Davies, 1998; Engleman et al., 1996; Engleman & Wild, 2003; Kingshott et al., 2000; Krieger, 1992;  Lewis Seale, Bartle, Watkins, Watkins, & Ebden, 2004; Pieters, Collard, Aubert, Dury, Delguste, & Rodenstein, 1996; Reeves-Hoche, Meck, & Zwillich, 1994; Sage, Southcott, & Brown, 2001) . A meter reading on CPAP machines provides an accurate measure of the number of hours that patients are using CPAP at pressure per night. Use of more than 4 hours per night has been quantified in the literature as "good" adherence (Collard et al., 1997; Haniffa, Lasserson, & Smith, 2004; Kingshott et al., 2000) . However, this represents use of CPAP as prescribed for up to only half of the night. No dose-response definition for optimal CPAP use currently exists. However, recent research suggests that a linear doseresponse curve is appropriate, whereby greater use during sleep is associated with greater improvement in daily functioning and reduced daytime sleepiness (Weaver et al., 2007) .
Without dosing guidelines, clinician goals for patient adherence tend to be for the patient to use the device as much as possible whilst sleeping.
Patient-reported reasons for not using CPAP
The reasons reported by patients for not using CPAP are usually associated with the side effects of the treatment. The most common side effects, reported in 15 to 45% of patients, are skin irritation, nose stuffiness and air leaks around the mask (Zozula & Rosen, 2001 ). Less common, but equally significant reported problems, are claustrophobic reactions to the mask, problems with spontaneous intimacy with the bed partner, and the noise of the machine (Engleman et al., 1996; Hui et al., 2001; Zozula & Rosen, 2001) .
Specific modifications to the CPAP device and interface (such as humidifiers, pads on the bridge of the nose to reduce irritation and reduced noise from the machine) have lessened or removed many but not all of these side effects. However, there has not been a corresponding increase in adherence rates proportional to the amount of reduction in side effects experienced with these newer machines (Haniffa et al., 2004; Malhotra et al., 2000; Patel et al., 2003; Perlis & Lichstein, 2003; Stepnowsky, Marler, & Ancoli-Isreal, 2002 ).
This suggests that the problem of CPAP adherence is not fully explained by mechanical issues with the CPAP device.
Investigation of psychological and motivational factors in CPAP adherence has led to a shift in the focus of patient treatment. Targeting patient attitudes towards the treatment, and improving these, has become a viable research avenue (Brostrom, Stromberg, Martensson, Ulander, Harder, & Svanborg, 2007; Weaver & Grunstein, 2008) . The following sections of this review will outline physiological and demographic predictors of CPAP adherence. Following this, recent research evidence investigating psychological modifiable predictors of CPAP adherence will be evaluated with the aim of identifying modifiable constructs that can be incorporated in the context of an inclusive theoretical model predictive of patient acceptance and adherence to treatment.
Physiological and Demographic Predictors of Adherence
Many empirical studies have investigated general predictors of CPAP adherence.
CPAP use may be associated with demographic factors such as male gender (Lewis et al., 2004; McArdle et al., 1999; Popescu, Latham, Allgar, & Elliot, 2001; Zozula & Rosen, 2001 ) lower age (McArdle et al., 1999; Zozula & Rosen, 2001 ) and the absence of a comorbid pulmonary disease (Lewis et al., 2004; McArdle et al., 1999) . There is large variability in the literature regarding the predictive power of physiological indices of OSA severity.
Greater adherence to CPAP appears to be associated with objective and subjective improvements in disease variables of sleep quality and daytime sleepiness (Collard et al., 1997; Drake et al., 2003; Meurice et al., 1994; Popescu et al., 2001) . Some studies have noted correlations (typically between r =.2 and r =.4) between the AHI and adherence (Drake et al., 2003; Edinger, Carwile, Miller, Hope, & Mayti, 1994; Engleman & Wild, 2003; Hui et al., 2001; Krieger, 1992; Lewis et al., 2004; McArdle et al., 1999; Meurice et al., 1994; Popescu et al., 2001; Zozula & Rosen, 2001) . Adherence is less consistently associated with lower prescribed CPAP pressure (CPAP pressure <12cm) (Engleman & Wild, 2003; Zozula & Rosen, 2001 ), higher BMI (BMI>30) (Edinger et al., 1994; McArdle et al., 1999; Popescu et al., 2001; Zozula & Rosen, 2001 ) and higher level of education (Hui et al., 2001; Kribbs et al., 1993) .
While demographic and physiological factors assist in the prediction of CPAP adherence, linear combinations of these physiological and demographic predictors rarely explain more than 10-15% of the variance in CPAP adherence (Engleman & Wild, 2003) .
Moreover, poor adherence rates are not specific to OSA or to CPAP. Studies of adherence to prescribed treatments for asthma (Bosley, Fosbury, & Cochrane, 1995) , narcolepsy (Rogers, Aldrich, Berrios, & Rosenberg, 1997) and diabetes (Balkrishnan et al., 2003) have shown that even with non-invasive pill or inhaler treatments with minor side effects, 40 -50% of patients do not take the medication as prescribed (Clark & Becker, 1998; DiMatteo, Giordani, Lepper, & Croghan, 2002) . Therefore, although treatment adherence is a significant problem for OSA patients, it is not a problem unique to this syndrome.
Motivational/Psychological factors in adherence to treatment
In a variety of chronic disorders requiring consistent adherence to a treatment regime (for example: diabetes, asthma and heart disease), social, emotional, personality and cognitive factors have been found to enhance the prediction of adherence (Connor & Norman, 1996; Kavanagh, Gooley, & Wilson, 1993) . Inclusion of psychological variables to physiological variables in predicting CPAP adherence has been found to substantially improve prediction (Edinger et al., 1994; Olsen, Smith, Oei & Douglas, in press;  Stepnowsky, Bardwell, Moore, Ancoli-Isreal, & Dimsdale, 2002; Stepnowsky, Marler et al., 2002) . Given these findings, there has been a call for the identification of psychological predictors of CPAP adherence that are amenable to intervention (Aloia, Arnedt, Riggs, Hecht, & Borrelli, 2004; Aloia et al., 2005; Drake et al., 2003; Engleman & Wild, 2003; Perlis & Lichstein, 2003) .
Psychological Predictors of Adherence
Physiological indices of the severity of sleep disordered breathing (for example, AHI) are not reliably correlated with patients' reported subjective symptom severity and quality of life (Chervin & Aldrich, 1999; ICSD-2, 2005; Zezirian, Harrison, Ancoli-Isreal, Redline, Ensrud, et al., 2007) . This indicates that a patients' subjective perception of the problem may not necessarily reflect the objective severity of the illness. Thus, objective severity may not reflect their need for treatment. The impact of these beliefs and motivations on CPAP use has only recently gained recognition within the OSA literature. Table 1 reports studies assessing the impact of psychological factors on CPAP adherence returned from Psyc-Info and Medline and database searches of combinations of the keywords "Obstructive Sleep Apnea", "Adherence" and "Psychology/Psychological". A particular focus in Table 1 is given to the strength and utility of psychological constructs derived from a sound theoretical and research basis. Strengths and limitations of each study are identified, as are the strength of the association between each variable or combination of variables with adherence. In developing a unified theory of CPAP adherence, an emphasis is given to previous research assessing constructs in the context of theoretical models of adherence, the use of prospective data collection and adequate sample sizes. (Engleman et al., 1996) and self-referrals for CPAP treatment (Hoy et al., 1999) . Other studies report no effect of ESS score prior to treatment on determining CPAP adherence (Hui et al., 2001; Olsen et al., in press; Stepnowsky, Marler et al., 2002) . However, subjective improvements in daytime and nocturnal symptoms with treatment, as demonstrated by an improvement in ESS score, may predict ongoing CPAP use (Engleman et al., 1996; Lewis et al., 2004; McFadyen, Espie, McArdle, Douglas & Engleman, 2001 ).
The degree to which patients report satisfaction with the treatment reliably correlates with adherence (Hui et al., 2001; Kribbs et al., 1993; Popescu et al., 2001 ). These subjective judgements of improvements in symptoms and daily functioning with treatment, as well as judgments about the severity of the associated side effects of the treatment, may be associated with personality style. A recent study by Brostrom and colleagues (2007) indicated that characteristics of negative affectivity and social inhibition associated with "Type D" personality predicted greater reporting of side effects of the treatment, and subsequent poorer adherence.
Generally, the contribution of psychological predictors of adherence support a conceptualisation of adherence as a balance between the subjective benefits of using CPAP as reported by the patient, versus the costs of using it. From the patient's perspective, the side effects of the treatment may be a sufficient "cost" of the treatment to outweigh the benefits of using the treatment.
Psychological Symptoms and CPAP adherence
Fewer symptoms of anxiety and depression at pre-treatment may be associated with better subsequent CPAP adherence (Edinger et al., 1994; Lewis et al., 2004) . Edinger and colleagues (1994) administered the MMPI to 28 male OSA patients as well as measures of daytime sleepiness and sleep quality before they had experienced CPAP. At six months follow-up, 63% of the variance in self-reported use of CPAP was explained by a combination of the MMPI hypochondriasis and depression scales, as well as BMI, sleepiness and sleep quality. Self-reported nightly CPAP use, rather than objective CPAP machine hours, was the adherence measure in this study. As self-reported use is highly subjective, the conclusions able to be drawn from this study are limited. In addition, the direction of the effect is unclear (Andrews & Oei, 2004) . It is unknown whether use of CPAP improves depressive symptoms, and this change predicts ongoing use, or alternatively, whether ongoing depressive symptoms with treatment impacts on subsequent adherence (Wells, Day, Carney, Freedland, & Duntley, 2004) .
Stepnowsky, Bardwell and colleagues (2002) investigated the predictive value of psychological variables of pre-treatment anxiety, depression and coping variables in the prediction of objective CPAP adherence. Twenty-three patients completed a psychological battery before experiencing CPAP, and adherence was measured at one week posttreatment initiation. They found that anxiety and depression did not correlate with CPAP adherence at one week. However, patients who used "active" ways of coping with life situations before starting treatment used CPAP more at follow up. "Active" coping refers to a tendency to use active means to manage difficult situations. 
Social Support and CPAP adherence
A large proportion of OSA patients are married or in long-term relationships (McFadyen et al., 2001; Stepnowsky, Marler et al., 2002; Wild, Engleman, Douglas, & Espie, 2004) . Spousal support has been identified as a potential mediating variable relating to treatment adherence in other health domains (Doherty, Schrott, Metcalf, & IasielloVailas, 1983; Jones, 2002) . Of particular importance may be the spouse's self-reported acceptance of a treatment (Doherty et al., 1983) and improvements in marital satisfaction with CPAP use (Kiely & McNicholas, 1997; McFadyen et al., 2001 ). More generally, partner support, relationship quality and self-efficacy have been found to be important predictors in cardiac patient's compliance with rehabilitation (Jones, 2002) . Consistent with this, living alone has been identified as a potential predictor of poorer CPAP adherence (Lewis et al., 2004) . The role of partner quality of life on CPAP adherence has not been addressed in previous research. Moreover, the role of marital satisfaction on CPAP adherence has only been addressed by one underpowered study (McFadyen et al., 2001 ). As such, the role of environmental factors such as social support and marital satisfaction on patient acceptance of CPAP treatment remains under researched.
Theoretical Models of CPAP Adherence
A limited number of studies have investigated explicit psychological models of adherence derived from other health domains (Aloia et al., 2005; Olsen et al., in press; Sage et al., 2001; Stepnowsky, Marler et al., 2002; Wild et al., 2004; Wong, 2001) . Prediction of CPAP adherence from a theory driven perspective has reduced some of the inconsistency noted in previous research. As outlined in Table 1 
Social Cognitive Theory (SCT) and Transtheoretical Model (TTM)
Bandura's SCT proposes that a patient's expectations for good or bad outcomes if the appropriate health behaviour is undertaken, and their belief in their ability to engage in the necessary behaviours to affect change (self-efficacy), are predictive of their subsequent engagment in these behaviours (Bandura, 1998; Britt, Hudson, & Blampied, 2004; Clark & Becker, 1998) . SCT also emphasises the importance of knowledge and social support in adherence (Stepnowsky, Marler et al., 2002) . TTM proposes that a patient's readiness to engage in the required adherence behaviour ("readiness to change") is important for subsequent adherence (Prochaska, Johnson & Lee, 1998) . Patients are conceptualised as moving through five stages of increasing readiness to change, from pre-contemplation (patient has no intention of engaging in the required health behaviour), contemplation, preparation (preparing to engage in the health behaviour within the next month), action and maintenance. Finally, the patients' subjective "weighing" of the pros and cons of the treatment (decisional balance) is also important in predicting adherence (Prochaska & DiClemente, 2005; Prochaska & Marcus, 1994 ). These models incorporate many aspects of the environmental, motivational and psychological factors identified in this review as important in predicting CPAP adherence. These include self-efficacy (Aloia et al., 2005; Sage et al., 2001) , spousal support, and the patient's subjective weighing of the pros and cons of the treatment.
Stepnowsky, Marler and Ancoli-Isreal (2002) investigated SCT and TTM measures in predicting CPAP adherence at one-month post-CPAP fitting. They developed specific OSA measures assessing self-efficacy, outcome expectations, social support, knowledge and process of change and decisional balance. Significant relationships were found between the patient's decisional balance after 1 week of using CPAP and adherence at 1 month. This relationship was predictive even when CPAP pressure was statistically controlled. SCT measures of self-efficacy and outcome expectancies also predicted adherence. While the SCT constructs measured at 1 week explained an additional 26% of the variance in CPAP adherence, the four measures did not individually predict adherence. This may suggest that inter-correlations between the predictors, rather than unique contributions of the predictors themselves, were responsible for predicting adherence. Therefore, CPAP adherence must be considered from a perspective of model building and testing, with clear predictions as to the complex interrelationships between predictors. Aloia and colleagues (2005) found that readiness, self-efficacy and decisional balance, when measured at 1 week and three months after the patient had started CPAP, predicted CPAP adherence at 6 months. These constructs did not predict adherence when measured before experience with CPAP. That is, TTM and SCT predictors are not predictive in the initial stages of treatment, but become predictive as the patients' exposure to the therapy increased. Readiness and self-efficacy were the most predictive constructs, explaining approximately 23% of the variance in CPAP adherence. Contrary to the research of Stepnowsky, Marler and colleagues (2002), decisional balance was only predictive of adherence at 6 months when measured at 1 week after commencing on CPAP. When objective adherence was included in the prediction equation, the TTM and SCT constructs failed to explain any additional variance. This suggests that objective early adherence predicts subsequent adherence, with TTM and SCT constructs adding little to the picture.
That is, these psychological variables are confounded by actual CPAP use, as they are not predictive before the patient has gained at least one week of exposure to the treatment.
Studies investigating the efficacy of TTM and SCT constructs in predicting CPAP adherence indicate that they add little variance above that explained by objective early adherence to the treatment. However, earlier research indicated that prediction of adherence before CPAP experience (treatment acceptance) using psychological variables is achievable (Edinger et al., 1994; McFadyen et al., 2001; Stepnowsky, Bardwell et al., 2002; Wild et al., 2004) . This early prediction is vital, given that up to 30% of patients have already rejected the treatment before, or shortly after their titration study (Collard et al., 1997) .
Therefore, other models of adherence may be better able to explain why patients do not initiate or accept CPAP treatment (Olsen et al., in press ). If psychological factors and beliefs which impact on CPAP adherence are in place even before patient takes the device home, then the goal of treatment is to enhance patient acceptance of the treatment early in the assessment and treatment process, as well as support adherence later on.
Social Learning Theory
Wallston's modified SLT emphasises that the patient's perception about the level of control they have over their illness will determine whether they change their behaviour to improve their health. Health Locus of Control is the central concept of this theory. This construct is subdivided into subscales of internality, powerful others and change. Patients who have a higher internal locus of control (i.e. they believe that they have control over their health) are more likely to adhere to treatment (Wallston, 1992; Wild et al., 2004) .
Patients with an external locus of control (i.e. they believe that their health is determined by external powerful others, such as a doctor, or is a matter of fate) will be less likely to adhere. The value one puts on their health (health value) is a moderator of the relationship between internal locus of control and health behaviour. That is, internal locus of control is only predictive of adherence when the patient values their health and their health outcome (Wallston, 1992) . Finally, treatment specific self-efficacy, or the belief that one can effectively overcome obstacles to adherence, predicts adherence (Connor & Norman, 1996) . Wild and colleagues (2004) investigated SLT constructs of locus of control, generalised self-efficacy, and health value in 119 CPAP naïve OSA patients. It was found that general self-efficacy was not predictive of adherence at 3 months after commencing CPAP. In constrast, OSA disease specific variables of ESS, AHI, CPAP pressure and body mass index (BMI) predicted 18% of the variance in CPAP adherence. Internal locus of control as well as a lower belief in powerful others and more health value independently predicted adherence. However, addition of the health locus of control and health value scales to the model only explained an additional 6% of the variance in adherence.
There are several methodological issues raised by Wild and colleagues' investigation of SLT. Although self-efficacy has been found to be a good predictor of adherence in other disorders (Connor & Norman, 1996; Jones, 2002) , and is also predictive in other studies of OSA (Aloia et al., 2005; Sage et al., 2001 ), self-efficacy was not predictive in this study. However, a generalised self-efficacy measure was used for prediction. Research has shown that only a belief in ones ability to overcome barriers related to a specific treatment (treatment specific self-efficacy) is predictive of adherence to treatment (Connor & Norman, 1996) . Therefore, Wallston's modified SLT has not yet been investigated strictly according to theory and remains a potentially useful model.
The Health Belief Model
The Health Belief Model (HBM) has been successfully applied to the prediction of compliance to several disease models (Clark & Becker, 1998; Connor & Norman, 1996; Juniper et al., 2004) and has been applied to CPAP adherence prediction (Olsen et al., in press; Sage et al., 2001) . HBM allows for the inclusion of demographic, psychological and psychosocial influences on adherence (Connor & Norman, 1996) . Although developed for the prediction of engaging in preventative health behaviours (such as wearing bicycle helmets; Quine, Rutter, & Arnold, 2000) the theory has been modified for specific illnesses.
According to HBM, the likelihood of engaging in health behaviour is based on readiness to act and expected benefit of the treatment. Readiness to act is determined by the patient's belief in their susceptibility to the illness consequences if they left their illness untreated, as well as the perceived seriousness of their illness. The patient's belief in the expected benefit of the treatment is based on their weighing of the perceived benefits to their health if they adhere to the treatment against the perceived barriers to action (Clark & Becker, 1998; Connor & Norman, 1996; Quine et al., 2000) . A cue to action, such as advice from a doctor, encouragement from the spouse, or a mass media campaign, acts as a trigger for the patient to commence healthy (adherence) behaviour (Quine et al., 2000) . Selfefficacy (confidence) in being able to use the treatment in the face of barriers, where barriers may present as side effects or the expense of the treatment, cements motivation to commence and continue with the treatment (Connor & Norman, 1996; Quine et al., 2000) .
In a prospective study of 40 Australian OSA patients, Sage and colleagues (2001) developed a CPAP questionnaire assessing HBM constructs. Patients completed the questionnaire after CPAP titration, and adherence was measured at one month follow-up. It was found that perceived benefits of using CPAP and the patients' belief in their ability to overcome obstacles to using CPAP (self-efficacy) were moderately positively correlated with CPAP adherence. Fewer concerns about barriers to using CPAP was also moderately correlated with CPAP adherence. Cues to action did not aid in the prediction of adherence.
Overall, the HBM constructs of benefits and barriers were better predictors of CPAP adherence than the objective severity measures of RDI, BMI and CPAP pressure, explaining an additional 23% of the variance in adherence.
This initial finding lends some support to the use of HBM constructs in the prediction of CPAP adherence. These constructs were predictive after only one night of CPAP experience (the titration study), indicating that the model may be of use in the early prediction of CPAP acceptance and adherence. A small sample size and use of HBM measures which were not empirically validated limitations the generalisability of the study.
These psychological constructs show potential in the prediction of adherence for OSA.
A further limitation of model testing in OSA to date is the use of simplistic, unidirectional regression models to predict relationships between psychological constructs and CPAP adherence. This approach overlooks the moderating and mediating relationships between many of these variables. For example, the TTM constructs of readiness and decisional balance, as well as the SCT constructs of outcome expectations may be moderated by self-efficacy. That is, readiness may not be predictive of adherence when the patient lacks self-efficacy in being able to continue to use the treatment (Connor & Norman, 1996; Prochaska & Prochaska, 2004) . These moderating relationships have not been addressed in studies previously applying psychological models to CPAP adherence.
Rather, previous studies have successfully applied measures from these models in regression equations, but have not tested the models in a way that addresses the interrelationships between these constructs.
A New Model of CPAP Acceptance and Adherence
Our research group has attempted to overcome the limitations of this previous research and utilise the HBM in prediction of both CPAP acceptance and adherence (Olsen et al., in press). We utilised a theoretically grounded, conceptual model of CPAP acceptance and adherence developed from HBM constructs. 
INSERT FIGURE 1 HERE
The previous adherence literature available (see Table 1 ) indicates that biomedical and psychological variables (such as depression and anxiety) do not directly influence CPAP adherence. These constructs indirectly influence adherence by adding to the patient's perceived risk of negative health outcomes and the perceived severity of the disorder. This impacts on how the patient weighs the pros (benefits) and cons (barriers) of use, which in turn affects their acceptance of the treatment. HBM predictors of perceived risk, severity, benefits and barriers, in the presence of a cue to take action, directly predict acceptance of CPAP. The decision to accept CPAP as a treatment option then feeds back to inform the degree to which the patient perceives benefits and barriers to treatment, and their confidence (self-efficacy) in being able to continue to adhere to the treatment. When combined with this feedback loop to the HBM constructs, CPAP acceptance will predict which patients continue to adhere to CPAP treatment at home. The basis of this model provides a foundation for informing the development of theoretically sound interventions for improving CPAP adherence.
Our initial validation study of this model (Olsen et al., in press) investigated HBM constructs in the prediction of CPAP adherence early in the treatment process. Patients were provided a psychological questionnaire after a diagnosis of OSA but prior to starting CPAP. Thus, they were naïve to the experience of actual physical side-effects of the treatment. CPAP adherence was measured at 4 month follow up. We hypothesised that patients would begin to develop expectations and beliefs regarding OSA and CPAP even before its use and before taking the treatment home from the hospital. We expected that patients who had already developed negative beliefs regarding the effectiveness of the treatment, undervalued the likely benefit they would experience in daily functioning with its use, as well as had low perceived disease severity would not fully accept the treatment from the outset and thus would be unlikely to adhere as recommended to the treatment in the long term. We utilised existing, validated, measures of constructs from the model including self-efficacy, perceived risk (susceptibility), functional outcomes (severity) and outcome expectancies (benefits).
Consistent with the HBM, we found that patient's expectancies regarding the effectiveness of the treatment (even prior to trying CPAP) predicted adherence at 4 months. 
Psychological Interventions for Improving CPAP Adherence
Psychological constructs are most powerful in predicting CPAP use, and a number of these constructs have the potential to be changed or modified. As CPAP modifications are now known to not improve adherence rates, resource allocation may be better targeted towards the identification of these modifiable, psychological predictors and then the development of interventions to specifically target them (Haniffa et al., 2004) . Behavioural and cognitive behavioural interventions, as well as home support interventions and education have been used with this population (Aloia et al., 2004; Haniffa et al., 2004; Richards, Bartlett, Wong, Malouff, & Grunstein, 2007; Smith, Lang, Sullivan, & Warren, 2004) . Table 2 presents studies investigating educational and behavioural interventions in adult OSA populations published to date, along with between group effect size estimates.
INSERT TABLE 2 Here
As demonstrated in Table 2 , six education based interventions (Chervin, Theut, Bassetti, & Aldrich, 1997; Fletcher & Luckett, 1991; Golay et al., 2006 (2000) and Chervin et al., (1997) , indicate that basic education provided early in the treatment process, may improve subsequent adherence rates. Specifically, these education programs involve providing information to new CPAP users about how to appropriately use CPAP, and how to overcome side effects related to treatment.
Hoy and colleagues (1999) reported 1.6 hours greater adherence for patients who received an additional CPAP titration night, education in their home which involved the partner, and regular follow-up visits for 4 months after treatment initiation compared to patients randomly assigned to standard CPAP support. The biggest effect size for change in CPAP adherence was noted by Chervin et al., (1997) , who found that participants who received literature outlining the importance of regular CPAP use, used CPAP 2.7 hours more than a standard control group (d=.99), and 1.4 hours more than a group who received weekly trouble-shooting phone calls.
The mechanisms by which changes in adherence behaviour occurs has not been directly tested. Education programs may increase patient self-efficacy in using the treatment. They may also provide a vehicle for building patient's beliefs in the expected health benefit to be derived if the treatment is used. Without direct measures of these constructs, there remains little validation for patient education as a method of modifying patient beliefs and expectations as is required to sustain adherence to treatment in the long term.
Two studies have investigated the impact of Cognitive-Behaviourally and
Motivational Interviewing orientated interventions on CPAP adherence, and compared these to standard care (Aloia and colleagues, 2001; Richards et al., 2007) . As demonstrated in Table 2 , large effect sizes of between 1.27 and 1.09 are demonstrated. Aloia and colleagues (2001) randomly assigned 12 OSA patients to either two sessions of brief instruction in the consequences of OSA and the efficacy of CPAP, or to a therapist timematched standard care condition. There was no difference in adherence between the groups at weeks one or four after treatment initiation. However, by 12 weeks of treatment, the CBT group were using CPAP an average 3.2 hours longer than participants in the control group (d=1.27). Moreover, despite a small sample size, which might account for the nonsignificant differences noted between the groups at 1 and 4 weeks follow-up, appropriate randomisation of groups and a therapist time-matched control was used.
Although presented as a cognitive-behaviourally based intervention, Aloia and colleagues (2001) describe a brief intervention more akin to Motivational Interviewing. In session 1 the advantages and disadvantages of the treatment, and pre-treatment PSG and other health symptoms are discussed before a goal for therapy is developed. Session 2 entails trouble-shooting, review of goals for treatment and development of realistic expectations with treatment. As with the education based treatments presented earlier, the mechanisms of change are not delineated, thus, the components of the treatment which affect the greatest change in patient beliefs and behaviour cannot be determined. It is possible that education about the treatment is sufficient to improve adherence rates.
Alternatively, the development of specific goals for use and promoting realistic expectations for treatment may be the powerful components. Additional research is required to determine theoretically stable and powerful treatment components from which to build an intervention to improve CPAP adherence.
Richards, Bartlett and colleagues (2007) also found a large effect size difference in treatment adherence in 50 patients who were randomly assigned to a group CBT intervention as compared to 50 patients who received treatment as usual (d=1.09). CBT consisted of group sessions including the patient and their partner, and targeted the identification and modification of faulty beliefs regarding the treatment. Moreover, videos showing "role models" persevering with the treatment were presented. Simple relaxation strategies were utilised to minimise anxious reactions as the patients tried on their masks.
Participants who completed the two, one hour CBT interventions used CPAP 2.9 hours more per night at 28 days after starting CPAP. In addition, the CBT group reported higher self-efficacy and social support. Without the addition of a therapist time-matched control group, and without controlling for partner involvement in both interventions, it is difficult to identify the precise mechanism of change in this study, although there is good evidence that self-efficacy and social support were important factors in patient use of CPAP at 28 days. The degree to which these changes persist in the long term is a target for future studies utilizing longer follow up time frames. This study represents the most rigorous study of this kind presented in the literature to date, and provides support for the use of psychological theory and intervention in targeting the problem of CPAP adherence.
In summary, psychological interventions used to improve adherence to CPAP have provided promising results. Methodological limitations associated with these need to be addressed in further research. Specifically, small sample sizes, and an atheoretical application of these interventions leaves the specific process of change involved with these open to interpretation. However, the better controlled studies of Aloia et al., (2001) , Hoy et al., (1999) , Chervin et al., (1997) and Richards et al., (2007) indicate that interventions designed to target motivational aspects of treatment acceptance, such as developing specific goals for CPAP use and building self-efficacy and a sense of social support, have some theoretical and empirical support for the problem of CPAP adherence.
Motivational Interviewing
Motivational Interviewing (MI) has gained recognition as an efficacious treatment for enhancing health behaviour for a variety of disorders, including reducing addictive behaviour such as smoking and alcohol dependence, and increasing treatment compliance (Burke, Arkowitz, & Menchola, 2003; Miller & Rollnick, 2002) . MI is a client-centered therapy designed to enhance a patient's readiness to change, or in the case of CPAP adherence, readiness to initiate and adhere to treatment. MI appears to be particularly relevant to the problem of CPAP adherence in OSA (Aloia et al., 2004) as it addresses the patient's ambivalence regarding CPAP use and is consistent with several models of the models of behaviour change (Britt et al., 2004) (Wild et al., 2004) . All of these models share three constructs which provide the basis for MI. These constructs are; 1) the patient's outcome expectations for using the treatment;
2) the patient's belief in their ability to engage in the behaviour (self-efficacy); and 3) the patient's readiness to engage in the behaviour (Miller & Rollnick, 2002) . The expected mechanism of change in this intervention is clear, precise and measurable. The use of MI with patients in the early phases of CPAP treatment shifts their focus from the negatives of the treatment to the positives of the treatment. This in turn theoretically increases their motivation to start using CPAP, and continue using CPAP in the long term. Therefore, exploration of the efficacy of a CPAP specific MI intervention in improving CPAP adherence rates is both theoretically and practically sound.
Directions for Future Research
Psychological constructs and theory have a lot to offer the real problem of poor adherence in this very serious disorder. However, there remains large gaps and inconsistencies in the psychological literature. Table 3 Testing: MMPI completed prior to CPAP experience CPAP use at 6 month follow-up assessed 28 participants retained for analysis.
Divided into "compliers" (N=20) and "noncompliers" (N=8).
Compliers had a higher BMI, lower subjective sleepiness, better sleep quality prior to treatment and lower depression and hypochondriasis scores. Testing: Equipped with a standard mask following CPAP titration. Followed for a mean 14 months after treatment (range=8-39 months).
Patients divided into "compliant" (N=30) (>5hrs) and non-compliant (N=14) groups. Compliers reported fewer side effects and were aware of the benefits of using CPAP.
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